Pubblicazioni

Venetoclax in CLL patients who progress after B-cell Receptor inhibitor treatment: a retrospective multi-centre Italian experience

2019 - BRITISH JOURNAL OF HAEMATOLOGY

Innocenti, I.; Morelli, F.; Autore, F.; Piciocchi, A.; Frustaci, A.; Mauro, F. R.; Schiattone, L.; Trentin, L.; Del Poeta, G.; Reda, G.; Rigolin, G. M.; Ibatici, A.; Ciolli, S.; Coscia, M.; Sportoletti, P.; Murru, R.; Levato, L.; Gentile, M.; D'Arena, G.; Efremov, D. G.; Tedeschi, A.; Scarfo, L.; Cuneo, A.; Foa, R.; Laurenti, L.

Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy

2018 - ANNALS OF HEMATOLOGY

Cicconi, L; Breccia, M; Franceschini, L; Latagliata, R; Molica, M; Divona, M; Diverio, D; Rizzo, M; Ottone, T; Iaccarino, L; Alfonso, V; Foa, R; Voso, Mt; Lo-Coco, F

Low-dose clofarabine in combination with a standard remission induction in patients aged 18-60 years with previously untreated intermediate and bad-risk acute myeloid leukemia or high-risk myelodysplastic syndrome: Combined phase I/II results of the EORTC/GIMEMA AML-14A trial

2017 - HAEMATOLOGICA

Selleslag, Dominik; Suciu, Stefan; Meloni, Giovanna; Muus, Petra; Halkes, Constantijn J. M.; Venditti, Adriano; Ramadan, Safaa M.; Pruijt, Hans; Meert, Liv; Vignetti, Marco; Marie, Jean-Pierre; Wittnebel, SÃ©bastian; de Witte, Theo; Amadori, Sergio; Willemze, Roelof; Baron, FrÃ©dÃ©ric